Article

VIDEO: Robert Frantz, MD, FACC, Discusses Costs Associated With Pulmonary Arterial Hypertension

Robert Frantz, MD, FACC, Director, Pulmonary Hypertension Clinic, Mayo Clinic, says that the issue of cost is an important factor in treating patients with pulmonary arterial hypertension.

Robert Frantz, MD, FACC, Director, Pulmonary Hypertension Clinic, Mayo Clinic, says that the issue of cost is an important factor in treating patients with pulmonary arterial hypertension. Dr Frantz also says that patients with pulmonary arterial hypertension who contract a blood stream infection will most likely require costly hospitalization and run the risk of other health issues.

This video was taken on Sunday, October 21 at the CHEST 2012 conference in Atlanta, GA.

Related Videos
Screenshot of an interview with Evangelia Vlachou, MD
Screenshot of an interview with Barry Goy, MD
Picture of San Diego skyline with words ASH Annual Meeting 2024 and health icons overlaid on the bottom
Screenshot of an interview with Amir Ali, PharmD, BCOP
Mansi Shah, MD, assistant professor, Rutgers Cancer Institute of New Jersey
 Alvaro Alencar, MD, associate professor of clinical medicine, chief medical officer, University of Miami Sylvester Comprehensive Cancer Center
Dr Cesar Davila-Chapa
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo